The bottled water boom of the 90s is now, some 20 years later, past its peak. Increasingly, people are becoming aware that all of those plastic bottles do not just magically appear, and more importantly, do not just magically disappear either. In addition, numerous studies and consumer reports tell us that as much as 25 percent of those bottles contain essentially the same water as we might get from the tap at around 1/2oth of the cost.
As far as what does come out of the tap, the EPA has recently decided to turn things up a notch in that area as well, by including not only substances known to pose health hazards to Americans directly, but also substances that are believed to work as precursors to potential health concerns–in other words, the causes behind the causes. Read More
In June 2008, the Technical Committee on Dietary Lipids of the International Life Sciences Institute North America sponsored a 2-day workshop to review research data on eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids for heart benefits, cancer, and cognitive decline. Previously in 2002, the Institute of Medicine concluded there was insufficient evidence available to define Dietary Reference Intakes (DRIs) for EPA and DHA. Since then, significant research data has emerged meriting a reassessment for DRI recommendations. The workshop concluded “consistent evidence from multiple research paradigms demonstrates a clear, inverse relationship between EPA+DHA intake and risk of fatal (and possibly nonfatal) coronary heart disease, providing evidence that supports a nutritionally achievable DRI for EPA+DHA between 250 and 500 mg/d.”
Researchers also note that evidence of beneficial effects of EPA+DHA for cognitive health is emerging. Read More